Whitehawk Therapeutics, Inc. (WHWK) stock
WHWKNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.13+0.05 (+1.62%)
Close on Nov 18, 2026Market cap $178.44MP/E –Yield –
Whitehawk Therapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Whitehawk Therapeutics's price to sales ratio was 26.5× on Apr 30, 2026, against 1.4× a year earlier. Over the last 5 years it ranged from 1.4× to 36.8×, with a median of 5.5×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Apr 30, 2026 | 26.5× | +18.5 |
| 2025 | Dec 31, 2025 | 7.9× | +4.8 |
| 2024 | Dec 31, 2024 | 3.1× | +1.0 |
| 2023 | Dec 29, 2023 | 2.1× | −11.0 |
| 2022 | Dec 30, 2022 | 13.1× | −23.7 |
| 2021 | Dec 31, 2021 | 36.8× | +35.0 |
| 2019 | Apr 30, 2019 | 1.9× | – |
See a number that looks wrong?